 Home > Active Ingredient News > Drugs Articles > BeiGene will report the results of the Phase 3 ALPINE clinical trial of Baiyueze vs. Ibrutinib for the treatment of chronic lymphocytic leukemia in EHA

BeiGene will report the results of the Phase 3 ALPINE clinical trial of Baiyueze vs. Ibrutinib for the treatment of chronic lymphocytic leukemia in EHA

 Last Update: 2021-06-18
 Source: Internet
 Author: User

Tags

gene therapy conference

neuroscience conference

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

BeiGene is a global biotechnology company focusing on the development and commercialization of innovative drugs worldwide
.

The company announced today that it will give an oral presentation at the chairperson’s seminar of the 26th European Hematology Association Annual Meeting (EHA2021) Network Conference in 2021.

BeiGene is a global biotechnology company focusing on the development and commercialization of innovative drugs worldwide

The interim analysis was based on 415 patients enrolled in the clinical trial, of which 207 received Baiyueze® treatment and 208 received Ibrutinib treatment
.

As previously announced, the ALPINE clinical trial reached its primary endpoint, that is, Baiyueze® demonstrated a non-inferiority objective response rate (ORR) evaluated by the investigator and the Independent Review Committee (IRC), and an objective response rate (ORR) evaluated by the investigator Superiority ORR

More detailed information about the results of the clinical trial of ALPINE will be provided by Peter Hillmen, professor of experimental hematology, BS, and Ph.

Original title: BeiGene announced that it will report on the 2021 European Hematology Association Annual Meeting (EHA2021) Chairman's Symposium on Baiyueze(R) (Zebutinib) vs.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Best Price Isopropylbenzylamine Crystal CAS 102-97-6 N-Isopropylbenzylamine Fast Delivery 99% crystal chemicals

CAS No.: 102-97-6

Pharmacy Grade

$2-2.2/MT EXW

Pregabalin Crystal CAS 148553-50-8 Lyrica Powder 99.0% White Powder Mobelbiochem

CAS No.: 148553-50-8

Pharmacy Grade

$35.00/KG FOB

PTD-DBM 99% freeze dried powder cas1199495-15-2

CAS No.: 1199495-15-2

Pharmacy Grade

$3-3.2/KG FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

announcements today(81)

80 20 company(94)

united states logo(227)

single use technology(195)

healthy food name(42)

ups united states(221)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.